FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376871304> ?p ?o ?g. }

• W4376871304 endingPage "1764" @default.
• W4376871304 startingPage "1754" @default.
• W4376871304 abstract "Among gynecological cancers, ovarian cancer has a high mortality rate. Cisplatin-based chemotherapy is commonly used for the treatment of ovarian cancer. However, the clinical efficacy of cisplatin in ovarian cancer is limited due to the development of chemo-resistance during treatment.In the study, we aimed to investigate the synergistic anti-cancer activity and targets of the FDA-approved drug disulfiram combined with cisplatin in ovarian cancer.The cell viability was determined by Celltier-Glo luminescent assay. The synergistic anti-cancer activity was assessed by combination index. Cell cycle and apoptosis were detected by flow cytometry. The in vivo anti-tumor activity and side effects were evaluated using a xenografted mice model. The synergistic anti-cancer targets were identified by a mass spectrometry-based proteomics analysis.In this study, we first found that disulfiram synergistically enhanced the anti-tumor activity of cisplatin in chemo-resistant ovarian cancer cells, which was accompanied by the enhanced induction of cellular apoptosis. Secondly, the in vivo study demonstrated that the combination treatment of disulfiram and cisplatin dramatically inhibited tumor growth and had no apparent side effects in ovarian cancer xenografted mice. Finally, proteomics analysis identified SMAD3 as a potential target of disulfiram-cisplatin combined treatment, and the down-regulation of SMAD3 could increase cisplatin-induced cell death in ovarian cancer.Combination treatment of disulfiram and cisplatin synergistically inhibited the growth of ovarian cancer through down-regulating SMAD3. As a repurposed drug, disulfiram could be quickly transformed into a clinic to overcome cisplatin resistance for the treatment of ovarian cancer." @default.
• W4376871304 created "2023-05-18" @default.
• W4376871304 creator A5000721562 @default.
• W4376871304 creator A5021784473 @default.
• W4376871304 creator A5028946364 @default.
• W4376871304 creator A5029602509 @default.
• W4376871304 creator A5030674062 @default.
• W4376871304 creator A5032938845 @default.
• W4376871304 creator A5036150410 @default.
• W4376871304 creator A5046597133 @default.
• W4376871304 creator A5049301997 @default.
• W4376871304 creator A5078949281 @default.
• W4376871304 creator A5081142955 @default.
• W4376871304 creator A5086187414 @default.
• W4376871304 date "2023-09-01" @default.
• W4376871304 modified "2023-10-01" @default.
• W4376871304 title "Proteomics Analysis Revealed Smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in Ovarian Cancer" @default.
• W4376871304 cites W1974466912 @default.
• W4376871304 cites W2045208621 @default.
• W4376871304 cites W2102539723 @default.
• W4376871304 cites W2292940302 @default.
• W4376871304 cites W2303705342 @default.
• W4376871304 cites W2412945422 @default.
• W4376871304 cites W2519697102 @default.
• W4376871304 cites W2570618306 @default.
• W4376871304 cites W2758733287 @default.
• W4376871304 cites W2766755551 @default.
• W4376871304 cites W2907245943 @default.
• W4376871304 cites W2920419627 @default.
• W4376871304 cites W2946579858 @default.
• W4376871304 cites W2948368848 @default.
• W4376871304 cites W2965238366 @default.
• W4376871304 cites W2979888464 @default.
• W4376871304 cites W2982396938 @default.
• W4376871304 cites W3003330162 @default.
• W4376871304 cites W3018541786 @default.
• W4376871304 cites W3023998452 @default.
• W4376871304 cites W3096324162 @default.
• W4376871304 cites W3099857122 @default.
• W4376871304 cites W3113691894 @default.
• W4376871304 cites W3190487211 @default.
• W4376871304 cites W3190502988 @default.
• W4376871304 cites W3206968698 @default.
• W4376871304 cites W4205274147 @default.
• W4376871304 cites W4211203170 @default.
• W4376871304 doi "https://doi.org/10.2174/1871520623666230516161200" @default.
• W4376871304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37194931" @default.
• W4376871304 hasPublicationYear "2023" @default.
• W4376871304 type Work @default.
• W4376871304 citedByCount "0" @default.
• W4376871304 crossrefType "journal-article" @default.
• W4376871304 hasAuthorship W4376871304A5000721562 @default.
• W4376871304 hasAuthorship W4376871304A5021784473 @default.
• W4376871304 hasAuthorship W4376871304A5028946364 @default.
• W4376871304 hasAuthorship W4376871304A5029602509 @default.
• W4376871304 hasAuthorship W4376871304A5030674062 @default.
• W4376871304 hasAuthorship W4376871304A5032938845 @default.
• W4376871304 hasAuthorship W4376871304A5036150410 @default.
• W4376871304 hasAuthorship W4376871304A5046597133 @default.
• W4376871304 hasAuthorship W4376871304A5049301997 @default.
• W4376871304 hasAuthorship W4376871304A5078949281 @default.
• W4376871304 hasAuthorship W4376871304A5081142955 @default.
• W4376871304 hasAuthorship W4376871304A5086187414 @default.
• W4376871304 hasConcept C121608353 @default.
• W4376871304 hasConcept C126322002 @default.
• W4376871304 hasConcept C143998085 @default.
• W4376871304 hasConcept C150903083 @default.
• W4376871304 hasConcept C185592680 @default.
• W4376871304 hasConcept C190283241 @default.
• W4376871304 hasConcept C207001950 @default.
• W4376871304 hasConcept C2776694085 @default.
• W4376871304 hasConcept C2778239845 @default.
• W4376871304 hasConcept C2778523461 @default.
• W4376871304 hasConcept C2780427987 @default.
• W4376871304 hasConcept C502942594 @default.
• W4376871304 hasConcept C55493867 @default.
• W4376871304 hasConcept C71924100 @default.
• W4376871304 hasConcept C86803240 @default.
• W4376871304 hasConcept C96232424 @default.
• W4376871304 hasConcept C98274493 @default.
• W4376871304 hasConceptScore W4376871304C121608353 @default.
• W4376871304 hasConceptScore W4376871304C126322002 @default.
• W4376871304 hasConceptScore W4376871304C143998085 @default.
• W4376871304 hasConceptScore W4376871304C150903083 @default.
• W4376871304 hasConceptScore W4376871304C185592680 @default.
• W4376871304 hasConceptScore W4376871304C190283241 @default.
• W4376871304 hasConceptScore W4376871304C207001950 @default.
• W4376871304 hasConceptScore W4376871304C2776694085 @default.
• W4376871304 hasConceptScore W4376871304C2778239845 @default.
• W4376871304 hasConceptScore W4376871304C2778523461 @default.
• W4376871304 hasConceptScore W4376871304C2780427987 @default.
• W4376871304 hasConceptScore W4376871304C502942594 @default.
• W4376871304 hasConceptScore W4376871304C55493867 @default.
• W4376871304 hasConceptScore W4376871304C71924100 @default.
• W4376871304 hasConceptScore W4376871304C86803240 @default.
• W4376871304 hasConceptScore W4376871304C96232424 @default.
• W4376871304 hasConceptScore W4376871304C98274493 @default.
• W4376871304 hasFunder F4320321001 @default.

• next